Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSD | P07339 | 2/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.50 |
| ▸ | P2RX7 | Q99572 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | MITF | O75030 | 1/20 | 0.47 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.45 |
| ▸ | GFER | P55789 | 3/20 | 0.45 |
| ▸ | MPO | P05164 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | KDM5A | P29375 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL182679 | 0.87 | CA1 (0.50) | CTSDCA1CA2CA9ALDH1A1 | |
| SCHEMBL189857 | 0.87 | CTSD (0.46) | CTSDCA1CA2CA9ALDH1A1 | |
| SCHEMBL29625279 | 0.87 | CTSD (0.46) | CTSDCA1CA2CA9ALDH1A1 | |
| SCHEMBL29970839 | 0.87 | CES2 (0.56) | CTSDCA1CA2CA9ALDH1A1 | |
| SCHEMBL1000202 | 0.86 | ALDH1A1 (0.48) | CTSDCA1CA2CA9ALDH1A1 | |
| SCHEMBL29017326 | 0.86 | CTSD (0.48) | CTSDCA1CA2CA9ALDH1A1 | |
| SCHEMBL3292111 | 0.86 | CTSD (0.44) | CTSDCA1CA2CA9ALDH1A1 | |
| SCHEMBL10557796 | 0.86 | P2RX7 (0.51) | CTSDCA1CA2CA9ALDH1A1 | |
| SCHEMBL21625558 | 0.86 | CA1 (0.49) | CTSDCA1CA2CA9ALDH1A1 | |
| SCHEMBL3292107 | 0.86 | CTSD (0.44) | CTSDCA1CA2CA9ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010099029-A1 | EPOXY COMPOSITIONS WITH IMPROVED MECHANICAL PERFORMANCE | CYTEC TECHNOLOGY CORP. (US) | 2010-09-02 | — | — | WO | claimed |
| US-20100222461-A1 | EPOXY COMPOSITIONS WITH IMPROVED MECHANICAL PERFORMANCE | CYTEC TECHNOLOGY CORP. (US) | 2010-09-02 | — | — | US | claimed |
| US-20260109086-A1 | METHOD OF FORMING A BONDED STRUCTURE | LOCKHEED CORP (US) | 2026-04-23 | — | — | US | disclosed |
| US-20250368869-A1 | PRIMER COMPOSITION FOR ADHESIVE BONDING AND METHOD OF USING THE SAME | CYTEC INDUSTRIES INC. (US) | 2025-12-04 | — | — | US | disclosed |
| US-12480010-B2 | Aqueous inkjet ink, aqueous inkjet ink set, and inkjet recording method | CANON KABUSHIKI KAISHA (JP) | 2025-11-25 | — | — | US | disclosed |
| US-12365819-B2 | Primer composition for adhesive bonding and method of using the same | CYTEC INDUSTRIES INC. (US) | 2025-07-22 | — | — | US | disclosed |
| US-12290611-B2 | Cell or tissue embedding device | JAPAN VAM & POVAL CO., LTD. (JP) | 2025-05-06 | — | — | US | disclosed |
| US-20250001647-A1 | RESIN INFUSED PI-SHAPED PREFORM AND JOINTS THEREOF | LOCKHEED CORP (US) | 2025-01-02 | — | — | US | disclosed |
| EP-3586824-B1 | CELL- OR TISSUE-EMBEDDING DEVICE | JAPAN VAM & POVAL CO LTD (JP) | 2024-09-04 | — | — | EP | disclosed |
| WO-2024161752-A1 | LAYERED FILM AND METHOD FOR MANUFACTURING SAME | ダイセルミライズ株式会社 | 2024-08-08 | — | — | WO | disclosed |
| US-20240166798-A1 | EPOXY RESIN COMPOSITION, PREPREG, AND FIBER-REINFORCED COMPOSITE MATERIAL | TORAY INDUSTRIES, INC. (JP) | 2024-05-23 | — | — | US | disclosed |
| US-20060052492-A1 | Polyacetal resin composition and process for producing same | POLYPLASTICS CO., LTD. (JP) | 2006-03-09 | — | — | US | disclosed |
| EP-1595918-A1 | Deodorizing agent and resin composition | Polyplastics Co., Ltd. (JP) | 2005-11-16 | — | — | EP | disclosed |
| US-6627714-B2 | Copolymerizing ethylene and dicyclopentadiene or tricyclopentadiene, and cyclic olefin in presence of metallocene catalyst to produce copolymer | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2003-09-30 | — | — | US | disclosed |
| EP-0970140-B1 | CROSSLINKED POLYASPARTATE SALTS AND A PROCESS FOR THEIR PRODUCTION | SOLUTIA INC (US) | 2003-06-04 | — | — | EP | disclosed |
| US-20020058767-A1 | Method for producing an olefin type copolymer having a cyclic structure | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2002-05-16 | — | — | US | disclosed |
| EP-1205497-A2 | Method for producing an olefin type copolymer having a cyclic structure | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2002-05-15 | — | — | EP | disclosed |
| EP-0970140-A1 | CROSSLINKED POLYASPARTATE SALTS AND A PROCESS FOR THEIR PRODUCTION | Solutia Inc. (US) | 2000-01-12 | — | — | EP | disclosed |
| US-5981761-A | Crosslinked polyaspartate salts a process for their production | SOLUTIA INC. (US) | 1999-11-09 | — | — | US | disclosed |
| WO-1998042771-A1 | CROSSLINKED POLYASPARTATE SALTS AND A PROCESS FOR THEIR PRODUCTION | SOLUTIA INC. (US) | 1998-10-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260109086-A1 | METHOD OF FORMING A BONDED STRUCTURE | CDH1, COL2A1, COL1A1 | CTSD 3891/4885CA1 491/4885CA2 2475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.